| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
74,688 |
67,819 |
$11.33M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
131,734 |
120,284 |
$10.93M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
35,563 |
31,423 |
$3.24M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
21,436 |
18,904 |
$2.85M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
9,596 |
8,490 |
$2.84M |
| 16020 |
|
6,069 |
3,586 |
$1.49M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
41,922 |
33,929 |
$1.41M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
20,626 |
19,269 |
$1.07M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,773 |
23,958 |
$1.02M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,285 |
23,792 |
$946K |
| 71046 |
Radiologic examination, chest; 2 views |
27,084 |
24,534 |
$906K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,752 |
5,179 |
$893K |
| G0378 |
Hospital observation service, per hour |
6,639 |
4,278 |
$863K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29,619 |
26,072 |
$851K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26,446 |
20,711 |
$774K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,575 |
1,494 |
$773K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,012 |
1,811 |
$746K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,164 |
1,937 |
$621K |
| 80053 |
Comprehensive metabolic panel |
88,227 |
75,943 |
$613K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,623 |
10,346 |
$587K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27,491 |
21,897 |
$521K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
40,418 |
18,092 |
$506K |
| 95811 |
|
1,080 |
1,020 |
$474K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
84,619 |
71,882 |
$426K |
| 11043 |
|
1,873 |
1,022 |
$367K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,301 |
1,039 |
$357K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,110 |
9,369 |
$357K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,439 |
4,068 |
$357K |
| 87631 |
|
2,426 |
2,317 |
$316K |
| 71045 |
Radiologic examination, chest; single view |
17,653 |
15,970 |
$308K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
799 |
710 |
$294K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,819 |
866 |
$243K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,860 |
4,296 |
$238K |
| 95812 |
|
1,793 |
1,660 |
$232K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,729 |
9,711 |
$230K |
| 36415 |
Collection of venous blood by venipuncture |
108,445 |
89,061 |
$206K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
1,055 |
604 |
$204K |
| 37238 |
|
25 |
24 |
$187K |
| 81025 |
|
27,369 |
24,592 |
$179K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
27,328 |
24,399 |
$165K |
| 81001 |
|
68,241 |
59,088 |
$143K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,148 |
7,602 |
$131K |
| 86141 |
|
12,348 |
10,642 |
$127K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,638 |
2,082 |
$126K |
| 84484 |
|
20,265 |
15,174 |
$122K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
415 |
362 |
$120K |
| 99215 |
Prolong outpt/office vis |
2,324 |
2,075 |
$116K |
| 74019 |
|
2,793 |
2,503 |
$99K |
| 96376 |
|
2,719 |
1,121 |
$92K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
378 |
294 |
$83K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,666 |
805 |
$82K |
| 94060 |
|
930 |
852 |
$81K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
610 |
580 |
$80K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,973 |
1,462 |
$80K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
758 |
605 |
$71K |
| 85027 |
|
12,476 |
10,575 |
$68K |
| 84702 |
|
5,334 |
4,574 |
$68K |
| 76770 |
|
619 |
586 |
$62K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,344 |
1,953 |
$58K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,190 |
1,017 |
$49K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
120 |
114 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,127 |
632 |
$41K |
| 93458 |
|
41 |
26 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,370 |
5,292 |
$36K |
| 82553 |
|
6,381 |
4,994 |
$35K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16,017 |
12,877 |
$35K |
| 87486 |
|
1,128 |
1,012 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,209 |
2,365 |
$33K |
| 87581 |
|
1,111 |
988 |
$33K |
| 87428 |
|
1,107 |
1,033 |
$33K |
| C1760 |
Closure device, vascular (implantable/insertable) |
370 |
320 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,050 |
920 |
$30K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,048 |
920 |
$30K |
| 87040 |
|
3,709 |
3,067 |
$29K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
373 |
307 |
$28K |
| C1769 |
Guide wire |
890 |
723 |
$27K |
| 94729 |
|
510 |
466 |
$27K |
| 83690 |
|
5,792 |
5,230 |
$27K |
| 74018 |
|
1,069 |
945 |
$27K |
| 86780 |
|
2,042 |
1,911 |
$26K |
| 37252 |
|
32 |
27 |
$25K |
| C1876 |
Stent, non-coated/non-covered, with delivery system |
44 |
41 |
$24K |
| 82550 |
|
7,305 |
6,133 |
$24K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
131 |
120 |
$23K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,018 |
936 |
$23K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
98 |
53 |
$21K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,971 |
14,716 |
$21K |
| 95012 |
|
353 |
347 |
$20K |
| 87088 |
|
2,522 |
2,334 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
479 |
245 |
$19K |
| 94726 |
|
442 |
405 |
$19K |
| 73100 |
|
630 |
498 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,831 |
1,746 |
$17K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
882 |
716 |
$16K |
| 84145 |
|
772 |
694 |
$16K |
| 76801 |
|
351 |
313 |
$15K |
| 95816 |
|
130 |
119 |
$15K |
| C1753 |
Catheter, intravascular ultrasound |
51 |
43 |
$14K |
| 94010 |
|
313 |
309 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,960 |
4,512 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
236 |
231 |
$13K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
148 |
135 |
$13K |
| 73080 |
|
410 |
319 |
$13K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,764 |
6,186 |
$13K |
| 86762 |
|
907 |
853 |
$13K |
| 83880 |
|
679 |
618 |
$12K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
28 |
26 |
$10K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
30 |
17 |
$10K |
| 87340 |
|
948 |
870 |
$9K |
| 81003 |
|
5,292 |
4,594 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
946 |
182 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
139 |
116 |
$9K |
| 86850 |
|
1,465 |
1,339 |
$8K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
129 |
81 |
$8K |
| 29075 |
|
98 |
82 |
$8K |
| 87070 |
|
1,249 |
1,095 |
$8K |
| 93225 |
|
189 |
180 |
$8K |
| 82962 |
|
3,082 |
2,349 |
$8K |
| 42830 |
|
14 |
12 |
$7K |
| 87807 |
|
682 |
604 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
458 |
442 |
$7K |
| 82677 |
|
308 |
288 |
$7K |
| 74021 |
|
165 |
160 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
92 |
88 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
76 |
69 |
$6K |
| 86803 |
|
423 |
396 |
$6K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
152 |
127 |
$5K |
| 82784 |
|
189 |
184 |
$5K |
| 86900 |
|
1,858 |
1,699 |
$5K |
| 86901 |
|
1,855 |
1,699 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
15 |
15 |
$5K |
| 73130 |
|
111 |
97 |
$5K |
| 86336 |
|
308 |
288 |
$5K |
| 82105 |
|
308 |
288 |
$5K |
| 82077 |
|
464 |
413 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
104 |
81 |
$4K |
| 72082 |
|
109 |
107 |
$4K |
| 84144 |
|
250 |
217 |
$4K |
| 82728 |
|
275 |
269 |
$4K |
| 86738 |
|
354 |
311 |
$4K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
14 |
13 |
$4K |
| 75710 |
|
44 |
27 |
$4K |
| J3480 |
Injection, potassium chloride, per 2 meq |
520 |
230 |
$4K |
| 86140 |
|
849 |
706 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
356 |
199 |
$3K |
| 82950 |
|
694 |
652 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,174 |
1,906 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,878 |
1,560 |
$3K |
| 85610 |
|
1,578 |
1,335 |
$3K |
| 84439 |
|
353 |
344 |
$3K |
| 85730 |
|
1,070 |
902 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27,449 |
21,635 |
$3K |
| 82785 |
|
156 |
153 |
$3K |
| 72100 |
|
85 |
76 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
288 |
256 |
$2K |
| 73610 |
|
70 |
55 |
$2K |
| 85007 |
|
958 |
793 |
$2K |
| 94762 |
|
186 |
90 |
$2K |
| 82787 |
|
170 |
165 |
$2K |
| 72170 |
|
70 |
52 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,813 |
930 |
$2K |
| 72081 |
|
105 |
92 |
$2K |
| 93226 |
|
32 |
29 |
$2K |
| 87077 |
|
257 |
233 |
$2K |
| 87186 |
|
265 |
227 |
$2K |
| 83020 |
|
138 |
136 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
42 |
36 |
$2K |
| 83615 |
|
350 |
207 |
$2K |
| 16000 |
|
47 |
43 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
500 |
199 |
$2K |
| 85046 |
|
254 |
244 |
$1K |
| 77072 |
|
27 |
26 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
28 |
26 |
$1K |
| 83540 |
|
227 |
222 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$1K |
| 36902 |
|
21 |
15 |
$1K |
| 83735 |
|
361 |
329 |
$1K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
860 |
454 |
$1K |
| 84550 |
|
343 |
200 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,564 |
1,023 |
$1K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
62 |
36 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
96 |
86 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,269 |
1,787 |
$1K |
| 97597 |
|
43 |
28 |
$1K |
| 82150 |
|
208 |
193 |
$1K |
| 97602 |
|
36 |
24 |
$982.69 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
154 |
135 |
$974.98 |
| 76536 |
|
12 |
12 |
$960.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,510 |
1,115 |
$953.48 |
| 84703 |
|
147 |
133 |
$881.17 |
| 84480 |
|
119 |
114 |
$823.32 |
| 84436 |
|
154 |
146 |
$770.94 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
409 |
350 |
$767.74 |
| 95957 |
|
29 |
28 |
$729.72 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
94 |
46 |
$689.33 |
| J7510 |
Prednisolone oral, per 5 mg |
169 |
149 |
$586.34 |
| 96367 |
|
13 |
13 |
$582.40 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
394 |
350 |
$543.38 |
| 77073 |
|
13 |
12 |
$536.16 |
| 73000 |
|
12 |
12 |
$521.04 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
546 |
483 |
$517.99 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
996 |
811 |
$499.10 |
| 87210 |
|
204 |
142 |
$473.28 |
| J7050 |
Infusion, normal saline solution, 250 cc |
64 |
37 |
$469.46 |
| 73630 |
|
14 |
12 |
$466.18 |
| 73090 |
|
13 |
12 |
$450.45 |
| 82043 |
|
75 |
72 |
$424.38 |
| 75822 |
|
15 |
13 |
$402.88 |
| 82248 |
|
112 |
82 |
$392.83 |
| J3360 |
Injection, diazepam, up to 5 mg |
25 |
12 |
$385.69 |
| 82570 |
|
75 |
72 |
$380.12 |
| 87081 |
|
52 |
49 |
$351.15 |
| 83605 |
|
63 |
53 |
$347.10 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
49 |
38 |
$307.06 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
330 |
72 |
$294.85 |
| 83021 |
|
20 |
15 |
$278.90 |
| 82247 |
|
76 |
52 |
$273.78 |
| C1755 |
Catheter, intraspinal |
30 |
27 |
$267.49 |
| 80143 |
|
25 |
24 |
$265.62 |
| 81511 |
|
221 |
163 |
$254.30 |
| 87427 |
|
12 |
12 |
$226.44 |
| 76937 |
|
166 |
136 |
$157.07 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,717 |
1,030 |
$153.11 |
| 87425 |
|
12 |
12 |
$146.52 |
| 85652 |
|
65 |
59 |
$144.30 |
| 80179 |
|
14 |
13 |
$134.25 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
30 |
27 |
$115.74 |
| 87045 |
|
12 |
12 |
$115.39 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$105.48 |
| 94760 |
|
59 |
38 |
$80.48 |
| 98960 |
|
277 |
219 |
$80.10 |
| 85379 |
|
12 |
12 |
$71.26 |
| 84100 |
|
27 |
26 |
$71.10 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
91 |
79 |
$69.61 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
12 |
12 |
$69.37 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
16 |
13 |
$68.58 |
| J2060 |
Injection, lorazepam, 2 mg |
26 |
26 |
$59.34 |
| 84156 |
|
13 |
12 |
$52.91 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
17 |
13 |
$47.26 |
| 85045 |
|
12 |
12 |
$45.17 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
238 |
164 |
$30.66 |
| 87205 |
|
22 |
12 |
$28.50 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
25 |
24 |
$25.44 |
| A9270 |
Non-covered item or service |
86 |
45 |
$22.49 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
69 |
44 |
$20.44 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
12 |
12 |
$14.95 |
| 30140 |
|
335 |
124 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
20 |
12 |
$0.00 |
| 97010 |
|
150 |
39 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
20 |
12 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
1,024 |
624 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,170 |
857 |
$0.00 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
120 |
102 |
$0.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
50 |
42 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
14 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
28 |
26 |
$0.00 |
| 02414 |
|
12 |
12 |
$0.00 |